Terms: = Gastric cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Treatment
16 results:
1. LncRNA SNHG26 promotes gastric cancer progression and metastasis by inducing c-Myc protein translation and an energy metabolism positive feedback loop.
Wu ZH; Wang YX; Song JJ; Zhao LQ; Zhai YJ; Liu YF; Guo WJ
Cell Death Dis; 2024 Mar; 15(3):236. PubMed ID: 38553452
[TBL] [Abstract] [Full Text] [Related]
2. gastric cancer mesenchymal stem cells promote tumor glycolysis and chemoresistance by regulating B7H3 in gastric cancer cells.
Gao Q; Huang C; Liu T; Yang F; Chen Z; Sun L; Zhao Y; Wang M; Luo L; Zhou C; Zhu W
J Cell Biochem; 2024 Mar; 125(3):e30521. PubMed ID: 38226525
[TBL] [Abstract] [Full Text] [Related]
3. circRPS19 affects hk2‑mediated aerobic glycolysis and cell viability via the miR‑125a‑5p/USP7 pathway in gastric cancer.
Zheng X; Shao J; Qian J; Liu S
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37449524
[TBL] [Abstract] [Full Text] [Related]
4. gastric cancer mesenchymal stem cells via the CXCR2/hk2/PD-L1 pathway mediate immunosuppression.
Huang C; Chen B; Wang X; Xu J; Sun L; Wang D; Zhao Y; Zhou C; Gao Q; Wang Q; Chen Z; Wang M; Zhang X; Xu W; Shen B; Zhu W
Gastric Cancer; 2023 Sep; 26(5):691-707. PubMed ID: 37300724
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis.
Xu J; Xu Y; Ye G; Qiu J
J Chemother; 2023 Oct; 35(6):527-538. PubMed ID: 36548909
[TBL] [Abstract] [Full Text] [Related]
6. Risks of malignancies among patients with psoriasis: A cohort study of 360 patients.
Watanabe T; Watanabe Y; Asai C; Asami M; Watanabe Y; Saigusa Y; Yamaguchi Y
J Dermatol; 2023 May; 50(5):615-621. PubMed ID: 36412216
[TBL] [Abstract] [Full Text] [Related]
7. Disrupting Circadian Rhythm via the PER1-hk2 Axis Reverses Trastuzumab Resistance in gastric cancer.
Wang J; Huang Q; Hu X; Zhang S; Jiang Y; Yao G; Hu K; Xu X; Liang B; Wu Q; Ma Z; Wang Y; Wang C; Wu Z; Rong X; Liao W; Shi M
Cancer Res; 2022 Apr; 82(8):1503-1517. PubMed ID: 35255118
[TBL] [Abstract] [Full Text] [Related]
8. IGF2-AS knockdown inhibits glycolysis and accelerates apoptosis of gastric cancer cells through targeting miR-195/CREB1 axis.
Yan B; Ren Z; Sun J; Ding C; Yang D
Biomed Pharmacother; 2020 Oct; 130():110600. PubMed ID: 34321174
[TBL] [Abstract] [Full Text] [Related]
9. [Recombinant methioninase regulates PI3K/Akt/Glut-1 pathway and inhibits aerobic glycolysis to promote apoptosis of gastric cancer cells].
Zhou L; Li S; Liu L; Zhou Q; Yuan Y; Xin L
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jan; 40(1):27-33. PubMed ID: 32376548
[TBL] [Abstract] [Full Text] [Related]
10. Histone methyltransferase SETD1A interacts with HIF1α to enhance glycolysis and promote cancer progression in gastric cancer.
Wu J; Chai H; Xu X; Yu J; Gu Y
Mol Oncol; 2020 Jun; 14(6):1397-1409. PubMed ID: 32291851
[TBL] [Abstract] [Full Text] [Related]
11. Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells.
Li Y; Xu Q; Yang W; Wu T; Lu X
Gene; 2019 Sep; 712():143956. PubMed ID: 31271843
[TBL] [Abstract] [Full Text] [Related]
12. Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells.
He J; Qi Z; Zhang X; Yang Y; Liu F; Zhao G; Wang Z
Anticancer Drugs; 2019 Jan; 30(1):19-26. PubMed ID: 30540594
[TBL] [Abstract] [Full Text] [Related]
13. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X
Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170
[TBL] [Abstract] [Full Text] [Related]
14. Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway.
Chen F; Zhuang M; Zhong C; Peng J; Wang X; Li J; Chen Z; Huang Y
Oncol Rep; 2015 Jan; 33(1):457-63. PubMed ID: 25333894
[TBL] [Abstract] [Full Text] [Related]
15. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
Hur H; Xuan Y; Kim YB; Lee G; Shim W; Yun J; Ham IH; Han SU
Int J Oncol; 2013 Jan; 42(1):44-54. PubMed ID: 23135628
[TBL] [Abstract] [Full Text] [Related]
16. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway.
Sun HW; Wu C; Tan HY; Wang QS
Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917
[TBL] [Abstract] [Full Text] [Related]
